GENEVA, March 9 -- NOEMA PHARMA AG (Barfusserplatz 34051 Basel) filed a patent application (PCT/EP2024/074250) for "METHODS OF TREATING A SLEEP DISORDER USING A TRIPLE REUPTAKE INHIBITOR" on Aug 30, 2024. With publication no. WO/2025/046050, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GARIBALDI, George (Hirzbodenpark 184052 Basel)

Abstract: Provided herein are methods of treating a sleep disorder (e.g., narcolepsy) in a subject in need thereof by administering to the subject compositions comprising a triple reuptak...